{"nct_id":"NCT02582242","title":"Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin","status":"COMPLETED","status_verified_date":"2019-05","start_date":"2015-10-19","start_date_type":"ACTUAL","primary_completion_date":"2017-03-18","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-18","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVO"]}